Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.
- Citation:
- Leuk Lymphoma vol 48 (7) 1290-8
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA-15083, CA-25224, CA-35103, CA-35113, CA-35195, CA-35269, CA-35448, CA-37404, CA-52352, CA-60276, CA-63849
- Corr. Author:
- Authors:
- David M Kurtz Loren K Tschetter Jacob B Allred Susan M Geyer Paul J Kurtin Wesley D Putnam Kendrith M Rowland Martin Wiesenfeld Gamini S Soori Richard C Tenglin Albert M Bernath Thomas E Witzig
- Networks:
- Study
- NCCTG-91-78-51
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adult, Aged, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Interleukin-4, Lymphoma, Non-Hodgkin, Male, Middle Aged, Recurrence, Salvage Therapy, Survival Analysis, Treatment Outcome